Citadel Advisors - ONCOGENEX PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 35 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Citadel Advisors ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$22,000
+144.4%
60,728
+188.6%
0.00%–
Q1 2017$9,000
-40.0%
21,042
-31.1%
0.00%–
Q4 2016$15,000
-48.3%
30,545
+27.5%
0.00%–
Q4 2015$29,000
-61.3%
23,962
-31.7%
0.00%–
Q1 2015$75,000–35,064–0.00%–
 Download
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q4 2016.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders